2023-504258-36-00已完成4 期
Bioequivalence of Ulipristal 30 mg Tablets in Healthy Subjects Under Fasting Conditions
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 60
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Amparo Amilburu
Scientific
Laboratorios Leon Farma S.A.
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Bioequivalence of Ulipristal 30 mg Tablets in Healthy Subjects Under Fed Conditions2023-504259-29-00Laboratorios Leon Farma S.A.44
已完成
4 期
Bioequivalence of Ruxolitinib 25 mg Tablets in Healthy Participants Under Fasting Conditions2025-520716-34-00Bluepharma Industria Farmaceutica S.A.28
已完成
1 期
A Study to Compare Blood Levels of Different Dosage Formulations of the Study Medicine That Is a CGRP Receptor Antagonist in Healthy AdultsNCT07261371Pfizer64
尚未招募
不适用
To Compare the Efficacy Of Tablet Ulipristal Acetate with inj GnRH agonist in Women with Fibroid UterusCTRI/2016/10/007336ot Applicable64
已完成
4 期
Bioequivalence of Apixaban 5 mg Film-Coated Tablets in Healthy Subjects Under Fasting Conditions.2023-506844-18-00Laboratorios Cinfa S.A.24